Treatment Guidelines from The Medical Letter
Drugs for Chronic Heart Failure
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
RECOMMENDATIONS - Unless there is a specific contraindication, all patients with heart failure and systolic dysfunction (LVEF ≤40%) should take both an ACE inhibitor and a beta blocker, and if volume overloaded, a diuretic as well. An angiotensin receptor blocker (ARB) is recommended for patients who cannot tolerate an ACE inhibitor. Addition of an aldosterone antagonist can be beneficial for patients with symptomatic heart failure or for patients with left ventricular dysfunction after a myocardial infarction. A combination of hydralazine and isosorbide dinitrate added to standard therapy has been effective in African-American patients with class III-IV heart failure. Digoxin can decrease symptoms and lower the rate of hospitalization for heart failure, but does not decrease mortality. There is no evidence that any drug improves clinical outcomes in patients with heart failure with preserved systolic function.

Chronic systolic ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Drugs for Chronic Heart Failure
Article code: 121a
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian